Page 77 - Multiple Sclerosis News Today

The Big Picture: Dr. Puja Uppal, Family Medicine, "If you have a high risk for Multiple Sclerosis, pay attention to these symptoms."Doctors Expert Insights About Autoimmune Conditions and Multiple Sclerosis

The Big Picture: Dr. Puja Uppal, Family Medicine, "If you have a high risk for Multiple Sclerosis, pay attention to these symptoms."Doctors Expert Insights About Autoimmune Conditions and Multiple Sclerosis

The Big Picture: Dr. Puja Uppal, Family Medicine, "If you have a high risk for Multiple Sclerosis, pay attention to these symptoms."Doctors Expert Insights About Autoimmune Conditions and Multiple Sclerosis

The Big Picture: Dr. Puja Uppal, Family Medicine, "If you have a high risk for Multiple Sclerosis, pay attention to these symptoms."Doctors Expert Insights About Autoimmune Conditions and Multiple Sclerosis

The Big Picture: Dr. Puja Uppal, Family Medicine, "If you have a high risk for Multiple Sclerosis, pay attention to these symptoms."Doctors Expert Insights About Autoimmune Conditions and Multiple Sclerosis

VANCOUVER - Having closed the door on her international career, Christine Sinclair can now focus on playing for the Portland Thorns — and helping others.

The Big Picture: Dr. Puja Uppal, Family Medicine, "If you have a high risk for Multiple Sclerosis, pay attention to these symptoms."Doctors Expert Insights About Autoimmune Conditions and Multiple Sclerosis

The Big Picture: Dr. Puja Uppal, Family Medicine, "If you have a high risk for Multiple Sclerosis, pay attention to these symptoms."Doctors Expert Insights About Autoimmune Conditions and Multiple Sclerosis

In a pioneering effort to address the limited treatment options for Australians grappling with progressive multiple sclerosis (MS), a groundbreaking adaptive clinical trial named PLATYPUS (PLatform Adaptive Trial for remYelination and neuroProtection in mUltiple Sclerosis) is set to commence in January 2024. The initiative, boasting an initial funding of $4 million, marks the first-ever adaptive […]

Differences in both the reasons for and rates of discontinuation of dimethyl fumarate for multiple sclerosis exist based on sex.